A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Rutgers, The State University of New Jersey
University Health Network, Toronto
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Karyopharm Therapeutics Inc